Literature DB >> 10698529

E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage.

S Jackson1, A Storey.   

Abstract

In addition to their role in anogenital cancer, human papillomaviruses (HPVs) are also involved in the development of a range of cutaneous lesions. HPV types 5 and 8 are associated with the development of skin cancers in individuals with Epidermodysplasia verruciformis (EV). A broad spectrum of HPV types are also commonly found in non-melanoma skin cancers in immunocompromised individuals, such as organ transplant recipients. The skin cancers in EV and immunocompromised patients occur predominantly at body sites exposed to ultra violet (UV) radiation, pointing to a key role for UV in their development. Here we show that the E6 protein from a range of cutaneous HPV types effectively inhibits apoptosis in response to UV damage. This occurs in both p53 null and wild type cells and does not require p53 degradation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698529     DOI: 10.1038/sj.onc.1203339

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  43 in total

1.  Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin.

Authors:  Michelle R Iannacone; Wei Wang; Heather G Stockwell; Kathleen O'Rourke; Anna R Giuliano; Vernon K Sondak; Jane L Messina; Richard G Roetzheim; Basil S Cherpelis; Neil A Fenske; Kristina M Michael; Tim Waterboer; Michael Pawlita; Dana E Rollison
Journal:  J Infect Dis       Date:  2012-06-01       Impact factor: 5.226

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 3.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

Review 4.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

5.  Genus beta human papillomavirus E6 proteins vary in their effects on the transactivation of p53 target genes.

Authors:  Elizabeth A White; Johanna Walther; Hassan Javanbakht; Peter M Howley
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

Review 6.  Roles of the immune system in skin cancer.

Authors:  S Rangwala; K Y Tsai
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

7.  Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation.

Authors:  S S Hampras; M Tommasino; Y Zhao; J L Messina; A R Giuliano; N A Fenske; B Cherpelis; R S Hesterberg; A A Akuffo; R P Amorrortu; J Balliu; L Vijayan; T Gheit; P K Epling-Burnette; D E Rollison
Journal:  Br J Dermatol       Date:  2019-02-10       Impact factor: 9.302

8.  The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.

Authors:  Roel E Genders; Hadi Mazlom; Angelika Michel; Elsemieke I Plasmeijer; Koen D Quint; Michael Pawlita; Els van der Meijden; Tim Waterboer; Hans de Fijter; Frans H Claas; Ron Wolterbeek; Mariet C W Feltkamp; Jan Nico Bouwes Bavinck
Journal:  J Invest Dermatol       Date:  2014-10-27       Impact factor: 8.551

Review 9.  Human papillomaviruses: shared and distinct pathways for pathogenesis.

Authors:  Denise A Galloway; Laimonis A Laimins
Journal:  Curr Opin Virol       Date:  2015-09-20       Impact factor: 7.090

10.  Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.

Authors:  Jose-Andres Mendoza; Yves Jacob; Patricia Cassonnet; Michel Favre
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.